A detailed history of Neuberger Berman Group LLC transactions in Insulet Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 6,133 shares of PODD stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,133
Previous 6,173 0.65%
Holding current value
$1.62 Million
Previous $1.25 Million 14.62%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$180.69 - $239.01 $7,227 - $9,560
-40 Reduced 0.65%
6,133 $1.43 Million
Q2 2024

Nov 14, 2024

BUY
$161.02 - $206.98 $111,747 - $143,644
694 Added 12.67%
6,173 $1.25 Million
Q2 2024

Aug 13, 2024

BUY
$161.02 - $206.98 $111,747 - $143,644
694 Added 12.67%
6,173 $1.25 Million
Q1 2024

Nov 14, 2024

SELL
$163.6 - $209.11 $11.2 Million - $14.4 Million
-68,747 Reduced 92.62%
5,479 $939,000
Q1 2024

May 13, 2024

BUY
$163.6 - $209.11 $896,364 - $1.15 Million
5,479 New
5,479 $939,000
Q4 2023

Nov 14, 2024

BUY
$127.77 - $221.42 $8.7 Million - $15.1 Million
68,053 Added 1102.43%
74,226 $16.1 Million
Q4 2023

Feb 09, 2024

BUY
$127.77 - $221.42 $473,643 - $820,803
3,707 Added 5.26%
74,226 $16.1 Million
Q3 2023

Nov 14, 2023

SELL
$154.67 - $290.89 $451,172 - $848,526
-2,917 Reduced 3.97%
70,519 $11.2 Million
Q2 2023

Aug 11, 2023

BUY
$272.48 - $330.23 $13,351 - $16,181
49 Added 0.07%
73,436 $21.2 Million
Q1 2023

May 12, 2023

SELL
$276.36 - $326.03 $7.95 Million - $9.38 Million
-28,761 Reduced 28.16%
73,387 $23.4 Million
Q4 2022

Feb 13, 2023

BUY
$212.22 - $313.46 $283,738 - $419,096
1,337 Added 1.33%
102,148 $30.1 Million
Q3 2022

Nov 15, 2022

BUY
$224.6 - $281.45 $215,616 - $270,192
960 Added 0.96%
100,811 $23.1 Million
Q2 2022

Aug 15, 2022

BUY
$186.4 - $279.02 $1.06 Million - $1.58 Million
5,660 Added 6.01%
99,851 $21.8 Million
Q1 2022

May 13, 2022

BUY
$194.8 - $275.7 $165,969 - $234,896
852 Added 0.91%
94,191 $25 Million
Q4 2021

Feb 11, 2022

SELL
$255.32 - $318.29 $11.9 Million - $14.8 Million
-46,537 Reduced 33.27%
93,339 $24.8 Million
Q3 2021

Nov 12, 2021

BUY
$260.36 - $307.27 $3,905 - $4,609
15 Added 0.01%
139,876 $39.7 Million
Q2 2021

Aug 13, 2021

SELL
$225.52 - $304.06 $11,276 - $15,203
-50 Reduced 0.04%
139,861 $38.3 Million
Q1 2021

May 13, 2021

BUY
$235.95 - $293.05 $48,605 - $60,368
206 Added 0.15%
139,911 $36.5 Million
Q4 2020

Feb 10, 2021

SELL
$215.97 - $265.89 $461,527 - $568,206
-2,137 Reduced 1.51%
139,705 $35.7 Million
Q3 2020

Nov 12, 2020

BUY
$192.55 - $236.59 $11,938 - $14,668
62 Added 0.04%
141,842 $33.6 Million
Q2 2020

Aug 13, 2020

BUY
$159.17 - $224.73 $82,927 - $117,084
521 Added 0.37%
141,780 $27.5 Million
Q1 2020

May 14, 2020

SELL
$130.01 - $216.44 $4.98 Million - $8.29 Million
-38,310 Reduced 21.33%
141,259 $23.4 Million
Q4 2019

Feb 12, 2020

SELL
$144.81 - $186.0 $4.19 Million - $5.38 Million
-28,904 Reduced 13.86%
179,569 $30.7 Million
Q3 2019

Nov 13, 2019

SELL
$117.35 - $167.95 $2.87 Million - $4.11 Million
-24,496 Reduced 10.51%
208,473 $34.4 Million
Q2 2019

Aug 13, 2019

BUY
$82.13 - $120.73 $78,352 - $115,176
954 Added 0.41%
232,969 $27.8 Million
Q1 2019

May 13, 2019

BUY
$72.44 - $101.87 $2.68 Million - $3.77 Million
37,015 Added 18.98%
232,015 $22.1 Million
Q4 2018

Feb 12, 2019

BUY
$73.27 - $105.19 $6.45 Million - $9.26 Million
88,000 Added 82.24%
195,000 $15.5 Million
Q3 2018

Nov 13, 2018

BUY
$81.43 - $108.13 $8.71 Million - $11.6 Million
107,000 New
107,000 $11.3 Million
Q2 2018

Aug 13, 2018

SELL
$83.27 - $101.93 $416,350 - $509,650
-5,000 Closed
0 $0
Q1 2018

May 08, 2018

SELL
$68.49 - $87.2 $273,960 - $348,800
-4,000 Reduced 44.44%
5,000 $433,000
Q4 2017

Feb 14, 2018

BUY
$55.67 - $71.8 $501,030 - $646,200
9,000
9,000 $621,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.